Return to News Categories

Commentary and Educational Cattle - Hogs / Livestock News Currencies News Energy News Grain News Index News Interest Futures News Metals Futures News Reports: Crops, CFTC, etc Soft Commodities News

Futures and Commodity Market News

Potential Revance Therapeutics (RVNC) Trade Has 21.26% Downside Protection

Feb 09, 2018 ( via COMTEX) --

A covered call identified by's patented algorithm on Revance Therapeutics (<a href="">RVNC</a>) could yield about 8.93% (20.25% annualized, for comparison purposes only) in 161 days. Pair a long position in the stock with the Jul 20, 2018 $25 call for a net debit of about $22.94. This position also has 21.26% downside protection. Revance Therapeutics closed at $29.14 Feb 8, 2018. Technical indicators for RVNC are bearish and support and resistance have been about $27.92 and $31.52, respectively.A

(C) Copyright 2018, All rights reserved.

Please read the End User Agreement.
By accessing this page, you agree to the terms and conditions of the End User Agreement.

News provided by COMTEX.

Lt Crude 5834.60
Nat Gas 8.301
Corn 367 4/8
Cotton #2 77.16
Gold 1349.4
Copper 3.2385
Euro 1.24300
USD Index 89.013
SP500 E-mini 2736.25
DJIA E-mini 25236